Migdal Insurance & Financial Holdings’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-85
Closed -$4K 615
2021
Q4
$4K Sell
85
-50
-37% -$2.61K ﹤0.01% 651
2021
Q3
$9K Hold
135
﹤0.01% 602
2021
Q2
$12K Sell
135
-10,919
-99% -$868K ﹤0.01% 529
2021
Q1
$753K Buy
11,054
+6,860
+164% +$533K 0.01% 270
2020
Q4
$304K Buy
+4,194
New +$243K ﹤0.01% 258

Other funds holding CDNA

Migdal Insurance & Financial Holdings's CDNA Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of CareDx (CDNA) in Q1 2022, closing a stake of 85 shares — an estimated $4K sold.

Migdal Insurance & Financial Holdings first reported a position in CDNA in Q4 2020 and held it in 5 quarters. The position peaked at $753K in Q1 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 85 CareDx shares in Q1 2022, an estimated $4K.
  • Migdal Insurance & Financial Holdings first reported a position in CareDx in Q4 2020 and held it in 5 quarters.
  • Migdal Insurance & Financial Holdings's CareDx position peaked at $753K in Q1 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.